Some studies have found individual genes to be significant drivers of ACC, such as β-catenin and insulin-like growth factor 2 [68,69], however these individual genes often only apply to very few cases and offer limited mechanistic understanding and therapeutic possibilities. This evidence concerns the gene IGF2 and adrenal cortex carcinoma.